Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.
Thomas BurmeisterAeint-Steffen StröhBritta KehdenHeiko TrautmannClaus MeyerRolf MarschalekPatrizia LargheroStefan SchwartzBjörn SteffenBernd SpriewaldThomas HeinickeNadja JäkelJörg WestermannKathrin NachtkampAndreas ViardotMax S ToppMartin NeumannClaudia Dorothea BaldusNicola GökbugetMonika BrüggemannPublished in: Leukemia (2024)